R&D Pipeline

Pipeline (2021-2030)

Others - Gene & Nucleic acids (3)

Modality Indication Targets Stage Company Project No. Detail
1 Development of novel AAV-based **** gene therapy for hearing loss
Gene & Nucleic acids Genetic hearing loss, Age-related hearing loss, Noise-induced hearing loss **** Hit Yonsei University RS-2026-25502919
2 Phase 1a clinical trial and approval of IND for phase 1b/2a clinical trial of androgenic alopecia therapeutics using cell.penetrating RNAi gene regulation technology
Gene & Nucleic acids Androgenetic alopecia androgen receptor Phase 1 Olix Pharmaceuticals RS-2023-00259300
3 Research on lead optimization of miRNA-based therapeutics for treatment of sarcopenia
Gene & Nucleic acids Sarcopenia Atrogin-1 Lead Aventi Inc. HN21C0500